125
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Inhibitory Effects of Egg Yolk Soluble Protein on Bone Resorption

, &
Pages 1929-1931 | Received 02 Aug 2007, Accepted 21 Apr 2008, Published online: 22 May 2014

  • 1) Katagiri, T., and Takahashi, N., Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis., 8, 147–159 (2002).
  • 2) Miyamoto, T., and Suda, T., Differentiation and function of osteoclasts. Keio J. Med., 52, 1–7 (2003).
  • 3) Leem, K., Kim, M., Kim, H., Kim, M., Lee, Y., and Kim, H. K., Effects of egg yolk protein on the longitudinal bone growth of adolescent male rats. Biosci. Biotechnol. Biochem., 68, 2388–2390 (2004).
  • 4) Ji, M. Y., Leem, K., Kim, M., and Kim, H. K., Egg yolk soluble protein stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biosci. Biotechnol. Biochem., 71, 1327–1329 (2007).
  • 5) Minkin, C., Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int., 34, 285–290 (1982).
  • 6) Kitaura, H., Sands, M. S., Aya, K., Zhou, P., Hirayama, T., Uthgenannt, B., Wei, S., Takeshita, S., Novack, D. V., Silva, M. J., Abu-Amer, Y., Ross, F. P., and Teitelbaum, S. L., Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J. Immunol., 173, 4838–4846 (2004).
  • 7) Lovibond, A. C., Haque, S. J., Chambers, T. J., and Fox, S. W., TGF-beta-induced SOCS3 expression augments TNF-alpha-induced osteoclast formation. Biochem. Biophys. Res. Commun., 309, 762–767 (2003).
  • 8) Toussirot, E., and Wendling, D., The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview. Expert Opin. Pharmacother., 5, 581–594 (2004).
  • 9) Ballanti, P., Minisola, S., Pacitti, M. T., Scarnecchia, L., Rosso, R., Mazzuoli, G. F., and Bonucci, E., Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry. Osteoporos. Int., 7, 39–43 (1997).
  • 10) Vaananen, K., Mechanism of osteoclast mediated bone resorption: rationale for the design of new therapeutics. Adv. Drug Deliv. Rev., 57, 959–971 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.